Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$540M |
| 2 |
Citizens Financial Group
CFG
|
+$304M |
| 3 |
Analog Devices
ADI
|
+$303M |
| 4 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$293M |
| 5 |
Travelers Companies
TRV
|
+$281M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$548M |
| 2 |
Micron Technology
MU
|
+$461M |
| 3 |
Citigroup
C
|
+$334M |
| 4 |
Broadcom
AVGO
|
+$319M |
| 5 |
AbbVie
ABBV
|
+$267M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.23% |
| 2 | Financials | 5.58% |
| 3 | Industrials | 4.98% |
| 4 | Consumer Discretionary | 4.95% |
| 5 | Healthcare | 4.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SCMP
6676
CALL
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $155K | ﹤0.01% |
+13,100
| New | +$147K |
|
|
AWP
6677
abrdn Global Premier Properties Fund
AWP
$366M
| $154K | ﹤0.01% |
7,765
+668
| +9% | +$13K |
|
6678
New Mountain Finance
NMFC
$730M
| $154K | ﹤0.01% |
+10,778
| New | +$153K |
|
6679
CALL
American Superconductor
AMSC
$1.55B
| $153K | ﹤0.01% |
+33,600
| New | +$130K |
|
|
BRFS
6680
DELISTED
BRF SA
BRFS
| $153K | ﹤0.01% |
+10,645
| New | +$139K |
|
6681
PUT
Novavax
NVAX
$1.33B
| $153K | ﹤0.01% |
6,695
+320
| +5% | +$7.16K |
|
6682
CALL
Ocular Therapeutix
OCUL
$2.2B
| $153K | ﹤0.01% |
24,700
-17,000
| -41% | -$109K |
|
|
I
6683
DELISTED
INTELSAT S. A.
I
| $153K | ﹤0.01% |
32,587
+15,913
| +95% | +$60.1K |
|
|
JMBA
6684
CALL
DELISTED
Jamba, Inc.
JMBA
| $153K | ﹤0.01% |
17,700
+4,500
| +34% | +$39.9K |
|
|
BCIC
6685
BCP Investment Corp
BCIC
$94.7M
| $152K | ﹤0.01% |
4,155
+1,488
| +56% | +$51.1K |
|
|
ATCO
6686
PUT
DELISTED
Atlas Corp.
ATCO
| $152K | ﹤0.01% |
21,400
-39,000
| -65% | -$268K |
|
|
OMED
6687
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $152K | ﹤0.01% |
33,587
-12,410
| -27% | -$50.3K |
|
6688
PUT
Costamare
CMRE
$1.77B
| $151K | ﹤0.01% |
24,500
-19,400
| -44% | -$126K |
|
6689
PUT
OFG Bancorp
OFG
$2.28B
| $151K | ﹤0.01% |
+16,500
| New | +$157K |
|
|
PNNT
6690
Pennant Park Investment Corp
PNNT
$243M
| $151K | ﹤0.01% |
20,135
-15,276
| -43% | -$115K |
|
|
CCEC
6691
Capital Clean Energy Carriers
CCEC
$1.36B
| $151K | ﹤0.01% |
6,166
-12
| -0.2% | -$304 |
|
|
KND
6692
CALL
DELISTED
Kindred Healthcare
KND
| $151K | ﹤0.01% |
22,200
-268,100
| -92% | -$2.28M |
|
6693
CALL
Talphera
TLPH
$63.8M
| $150K | ﹤0.01% |
+1,630
| New | +$102K |
|
6694
CALL
Direxion Daily FTSE China Bear 3X ETF
YANG
$99.1M
| $150K | ﹤0.01% |
100
-6
| -6% | -$10.1K |
|
|
MEET
6695
PUT
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $150K | ﹤0.01% |
41,300
-3,200
| -7% | -$13.6K |
|
|
VG
6696
CALL
DELISTED
Vonage Holdings Corporation
VG
| $150K | ﹤0.01% |
18,400
-6,500
| -26% | -$48.9K |
|
6697
CALL
Citizens
CIA
$201M
| $149K | ﹤0.01% |
20,300
-5,500
| -21% | -$42.4K |
|
6698
PUT
8x8 Inc
EGHT
$300M
| $149K | ﹤0.01% |
11,000
-10,900
| -50% | -$148K |
|
6699
CALL
NeoGenomics
NEO
$2.05B
| $149K | ﹤0.01% |
+13,400
| New | +$130K |
|
6700
Ooma
OOMA
$572M
| $149K | ﹤0.01% |
14,108
-94,494
| -87% | -$832K |
|
Similar funds
Ken Griffin's Q3 2017 Portfolio in Review
As of Q3 2017, Ken Griffin held 8,628 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Ken Griffin's Q3 2017 filing shows 1,223 new, 3,315 increased, 2,707 reduced and 1,164 closed positions. Its largest new stake was Goldman Sachs: 2,394,331 shares worth $568M. The largest sale was Visa, an estimated $548M.
By sector, the portfolio is most concentrated in Technology at 7.2% of assets, down from 7.4% a quarter earlier, followed by Financials and Industrials.
- Ken Griffin's largest Q3 2017 buy was Goldman Sachs: 2,394,331 shares worth $568M.
- Ken Griffin added most to Citizens Financial Group in Q3 2017, an estimated $304M increase.
- Ken Griffin's biggest Q3 2017 reduction was Visa, cutting an estimated $548M.
- Ken Griffin fully exited Citigroup in Q3 2017, selling an estimated $334M.
- Ken Griffin's ten largest holdings make up 17% of its $130B portfolio in Q3 2017.
- Ken Griffin opened 1,223 new positions and closed 1,164 in Q3 2017.
- Ken Griffin's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Citadel Advisors's 13F filing for Q3 2017, filed 9 Nov 2017.